CLINICAL_TRIALS
research
· 2025-03-26
Clinical Trial Update: Ischemic Post-conditioning in Acute Ischemic Stroke Thrombectomy (PROTECT-2) [Phase 2]
Summary
Phase 2 clinical trial PROTECT-2 is evaluating ischemic post-conditioning during thrombectomy for acute ischemic stroke; currently recruiting.
Upgrade for the full analysis, importance score, and drug timeline.
Diseases / indications
Snippet
Sponsor: Capital Medical University | Conditions: Acute Ischemic Stroke | Phase 2 | Status: RECRUITING